FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology and veterinary parasitology, in particular, to canine babesiosis. Described is a polypeptide, which is a novel canine Babesia antigen (CBA). Also disclosed is a composition comprising said antigen, nucleic acid encoding said antigen, antibody against said antigen, and medical uses of said antigen in vaccines against canine Babesiosis.
EFFECT: disclosed group of inventions can be used in veterinary science.
19 cl, 9 dwg, 5 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
VACCINE COMPOSITION FOR CONTROLLING INFESTATION WITH ECTOPARASITES | 2011 |
|
RU2585226C2 |
INFLUENZA INFECTING DOGS AND USE THEREOF | 2014 |
|
RU2711807C2 |
FLU VIRUS, CAPABLE OF INFECTING CANIDAE AND ITS APPLICATION | 2006 |
|
RU2520081C2 |
COMPOSITIONS OF RECOMBINANT CDV AND ITS USE | 2011 |
|
RU2567337C2 |
OspA CHIMERIC GENES, PROTEINS, AND METHODS FOR THEIR USE | 2011 |
|
RU2636455C2 |
OSPA CHIMERIC GENES, PROTEINS AND METHODS FOR USE THEREOF | 2011 |
|
RU2583289C2 |
VACCINE, SET AND TREATMENT AND PREVENTION METHOD OF ANIMALS-COMPANIONS' PARADONTOSIS | 2005 |
|
RU2364417C2 |
VACCINE AGAINST LYME DISEASE IN DOGS | 2018 |
|
RU2785620C2 |
RECOVERING VIRUS RELATED TO CANINE PARVOVIRUS-2 FROM RACOON | 2010 |
|
RU2565538C2 |
GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO | 2015 |
|
RU2799086C2 |
Authors
Dates
2016-10-10—Published
2011-12-28—Filed